Table 2:
Category | Total |
---|---|
All adverse events – no. | 15 |
Treatment-related adverse events* – no. | 4 |
Neutropenia | 1 |
Decreased hemoglobin | 1 |
Elevated liver function tests | 1 |
Peripheral eosinophilia | 1 |
Patients with ≥1 treatment-related adverse event – no. (%) | 1 (10%) |
Grade 4 adverse events – no. | 4 |
Sports-related concussion | 2 |
Sports-related fall and injury | 1 |
Emergency room visit after baseline food challenge | 1 |
Treatment-related serious adverse events – no. | 0 |
Patients who discontinued treatment or study because of an adverse event – no. (%) | 0 (0%) |
Adverse events that were assessed as being “possibly” or “probably” related to treatment by the study investigator were recorded as being related to the study drug.